Moleculin Biotech, Inc. · NASDAQ:MBRX

Klemp Walter V exercised options for 57 Moleculin Biotech, Inc. shares (Form 4)

Traded Nov 4, 2026 · Filed Nov 6, 2026

On Nov 4, 2026, Klemp Walter V (Director, CEO and President) exercised options for 57 Moleculin Biotech, Inc. shares, leaving 36,203 shares. Filed Nov 6, 2026 (Form 4).

Options exercised
57 shares
Holding after
36,203 shares
Trading plan
No
Role
Director, CEO and President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 4, 2026Common StockOption exercise5736,217Direct
Nov 4, 2026Common StockShares withheld for tax14US$8.4636,203Direct

Source

Download original · View original at SEC

Related